Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Alabama at Birmingham
Centre Oscar Lambret
NeoImmuneTech
M.D. Anderson Cancer Center
Pheon Therapeutics
DualityBio Inc.
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Tanabe Pharma America, Inc.
CRISPR Therapeutics
Nuvectis Pharma, Inc.
CNAO National Center of Oncological Hadrontherapy
GlaxoSmithKline
Marengo Therapeutics, Inc.
Numab Therapeutics AG
Laval University
Laval University
Stanford University
Tampere University Hospital
Grupo Español de Investigación en Cáncer de Ovario
University of California, San Diego
Cancer Research UK
Elucida Oncology
The First Affiliated Hospital with Nanjing Medical University
Advaxis, Inc.
Fujian Cancer Hospital
Evopoint Biosciences Inc.
Centre Leon Berard
Catalysis SL
Celon Pharma SA
Myeloid Therapeutics
Multitude Therapeutics Inc.
Kineta Inc.
Queensland Centre for Gynaecological Cancer
Instituto do Cancer do Estado de São Paulo
Genelux Corporation
Tanta University
H. Lee Moffitt Cancer Center and Research Institute
Catalysis SL
Andes Biotechnologies
University of California, San Diego
Eli Lilly and Company
University of Kentucky
Jiangsu Cancer Institute & Hospital
Ipsen
Jiangsu Cancer Institute & Hospital
MultiVir, Inc.
Abramson Cancer Center at Penn Medicine
Radboud University Medical Center